ASMS

Volaris Reports March 2024 Traffic Results: 87% Load Factor

Retrieved on: 
Thursday, April 4, 2024
ASM, Revolutions per minute, Pratt & Whitney, BMV, VLRS, ULCC, Yoy, ASMS, Volaris, Airline

de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, reports its March 2024 preliminary traffic results.

Key Points: 
  • de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, reports its March 2024 preliminary traffic results.
  • In March 2024, Volaris' ASM capacity decreased by 15.8% year-over-year due to the accelerated Pratt & Whitney engine inspections and the resulting aircraft groundings.
  • However, load factor increased by 1.3 pp YoY to 86.8%, as RPMs decreased by less than capacity.
  • Throughout the quarter, we achieved a robust load factor, with a well-balanced market mix aimed at maximizing profitability.”

Volaris Reports February 2024 Traffic Results: 86% Load Factor

Retrieved on: 
Wednesday, March 6, 2024
CITY, Pratt & Whitney, ASM, ULCC, BMV, Revolutions per minute, ASMS, Yoy, Volaris, VLRS, Airline

de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, reports its February 2024 preliminary traffic results.

Key Points: 
  • de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, reports its February 2024 preliminary traffic results.
  • In February 2024, Volaris' ASM capacity decreased by 13.7% year-over-year due to the extraordinary Pratt & Whitney engine accelerated inspections and the resulting aircraft groundings.
  • RPMs decreased by 10.9%, resulting in a load factor increase of 2.8 pp YoY to 85.9%.
  • Moreover, a robust load factor was achieved in February, exceeding the average for such a low-season month.

Volaris Reports Financial Results for the Fourth Quarter 2023: Net Income of USD $112 million

Retrieved on: 
Monday, February 26, 2024
LTM, Investment, ADS, Pratt & Whitney, Volaris, CASM, ASMS, Airline

Total operating expenses in the quarter were $735 million, representing 82% of total operating revenue, compared to 93% in the fourth quarter of 2022.

Key Points: 
  • Total operating expenses in the quarter were $735 million, representing 82% of total operating revenue, compared to 93% in the fourth quarter of 2022.
  • Income tax expense for the quarter was $17 million, compared to $44 million registered in the same period of 2022.
  • Net cash flow provided by operating activities was $730 million, while cash used in investing and
    financing activities were $462 million and $214 million, respectively.
  • The financial debt amounted to $653 million, while total lease liabilities stood at $2,906 million, bringing the net debt to $2,770 million.

Frontier Airlines Reports Fourth Quarter 2023 Financial Results

Retrieved on: 
Tuesday, February 6, 2024
Security (finance), VFR, Growth, GAAP, Airbus A320neo family, Visiting friends and relatives, Friends, Public expenditure, ASMS, Risk, Relatives

During the fourth quarter of 2023, Frontier generated 105 ASMs per gallon, a 3 percent improvement compared to the 2022 quarter.

Key Points: 
  • During the fourth quarter of 2023, Frontier generated 105 ASMs per gallon, a 3 percent improvement compared to the 2022 quarter.
  • Frontier took delivery of four A321neo aircraft during the fourth quarter of 2023, increasing the proportion of the fleet comprised of the more fuel-efficient A320neo family aircraft to 79 percent as of December 31, 2023, the highest of all major U.S. carriers.
  • The A321neo is expected to unlock meaningful scale efficiencies by way of fuel savings and higher average seats per departure.
  • Capacity is anticipated to grow 5 to 7 percent compared to the 2023 quarter.

Sun Country Airlines Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Wednesday, January 31, 2024
EPS, Growth, GAAP, Sun Country Airlines, Amazon, Marketing, ASMS, Aviation, Boeing 737 Next Generation, CASM, Aircraft, Airline

MINNEAPOLIS, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Sun Country Airlines Holdings, Inc. (“Sun Country Airlines,” “Sun Country,” the “Company”) (NASDAQ: SNCY) today reported financial results for its fourth quarter and full year ended December 31, 2023.

Key Points: 
  • For the fourth quarter of 2023, the Company reported total revenue of $245.5 million, which was 8.1% more than the fourth quarter of 2022.
  • The fourth quarter 2023 total fare per passenger of $156.39 was less than fourth quarter 2022 by 11.8% while scheduled load factor of 84.7% was little changed versus last year.
  • In the fourth quarter of 2023, cargo revenue was $25.3 million, a 3.6% increase versus the fourth quarter of 2022.
  • This combination drove adjusted CASM(3) in the fourth quarter lower by 2.2% versus the fourth quarter 2022.

Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)

Retrieved on: 
Tuesday, January 2, 2024
Biotechnology, Neurology, Health, Pharmaceutical, Clinical Trials, Diarrhea, DSM-IV codes, Cannabidiol, Lethargy, Partnership, Constipation, Clobazam, Aes, Lamotrigine, Caregiver, Principal, Research, LGS, TID, DEE, ASMS, Medication, Data, Physician, Somnolence, MD, Doctor of Philosophy, DS, SAE, Seizure, Combination, Pharmacokinetics, Appetite, Participation, Patient, Diagnosis, Safety, Levetiracetam, MSCE, Pharmaceutical industry

Of the 52 participants enrolled in the study, 43 participants were randomized to bexicaserin (DS=4, LGS=24, DEE Other=15) and 9 to placebo (DS=0, LGS=5, DEE Other=4).

Key Points: 
  • Of the 52 participants enrolled in the study, 43 participants were randomized to bexicaserin (DS=4, LGS=24, DEE Other=15) and 9 to placebo (DS=0, LGS=5, DEE Other=4).
  • The median number of countable motor seizures per 28-day period at baseline was 38.8 in the bexicaserin group compared to 20.8 in the placebo group.
  • Most participants (85.7%) in the bexicaserin treated group (n=35) that started the maintenance period tolerated the highest dose (12 mg).
  • 100% of the participants who completed the PACIFIC Study elected to enroll in the ongoing 52-week open-label extension study.

Volaris Reports November 2023 Traffic Results: 90% Load Factor

Retrieved on: 
Tuesday, December 5, 2023
Category 1, P&W, ASMS, Volaris, Pratt & Whitney, ULCC, Yoy, VLRS, Revolutions per minute, CITY, BMV, ASM, GTF, Airline

MEXICO CITY, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B.

Key Points: 
  • MEXICO CITY, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B.
  • de C.V. (NYSE: VLRS and BMV: VOLAR) ("Volaris" or "the Company"), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central, and South America, reports its November 2023 preliminary traffic results.
  • In November 2023, Volaris' ASM capacity decreased by 2.2% year-over-year, while RPMs decreased by 0.2%; the result was a load factor increase of 1.8 pp YoY to 89.8%.
  • Volaris transported 2.7 million passengers during the month, a 0.9% decrease compared to November 2022.

Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)

Retrieved on: 
Saturday, December 2, 2023
Xenon, Quality of life, Skill, SCN1A, Convention, Aes, Efficacy, Depression, Epilepsy, AES, Poster, American Epilepsy Society, ASMS, DSM-IV codes, SFG, Seizure, MPC, Dravet syndrome, Anxiety, Annual general meeting, Neurology, Food, Safety, MDD, Patient, Orange County Convention Center, OLE, Pharmaceutical industry

VANCOUVER, British Columbia, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will provide updates on its neurology programs at the Annual Meeting of the American Epilepsy Society (AES 2023).

Key Points: 
  • VANCOUVER, British Columbia, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will provide updates on its neurology programs at the Annual Meeting of the American Epilepsy Society (AES 2023).
  • Importantly, we are looking forward to presenting new interim data from our ongoing open-label extension study from our Phase 2b X-TOLE trial.
  • The exhibit will also feature the topline results from the Phase 2 proof-of-concept X-NOVA clinical trial in major depressive disorder.
  • Posters will be added to the Xenon website consistent with AES 2023 conference guidelines.

AGI Joplin Facility Celebrates a 3-Year Safety Milestone in No Lost Time Incidents

Retrieved on: 
Tuesday, November 28, 2023
Packaging, Engineering, Manufacturing, Safety, Workforce, Risk, Canadian Welding Bureau, Multimedia, AGI, Element, CPR, CWB, Child Passenger Safety Week, American Welding Society, LTI, Environment, Disability, Safety management system, Installation, ASMS, Sanders, AWS, Injury, Transport, Welding, Management, Pharmaceutical industry

Ag Growth International (“AGI”) announced that its Joplin, Missouri manufacturing facility has achieved a significant safety milestone with an impressive three years of no lost time incidents.

Key Points: 
  • Ag Growth International (“AGI”) announced that its Joplin, Missouri manufacturing facility has achieved a significant safety milestone with an impressive three years of no lost time incidents.
  • “We are delighted to celebrate this 3-year accomplishment with employees at the Joplin, MO facility.
  • The milestone exemplifies AGI’s worldwide commitment to workplace safety,” says Paul Householder, AGI President & CEO.
  • With safety as a companywide core priority, AGI has implemented a comprehensive Safety Management System (ASMS), that proactively monitors and guides performance at the facility level.

ALLEGIANT REPORTS OCTOBER 2023 TRAFFIC

Retrieved on: 
Wednesday, November 22, 2023
Atmosphere of Earth, Heart, News, Travel, Allegiant, ASMS, Allegiant Air, Total, Airline

Fixed fee flying is better measured through dollar contribution versus operational statistics.

Key Points: 
  • Fixed fee flying is better measured through dollar contribution versus operational statistics.
  • Las Vegas-based Allegiant (NASDAQ: ALGT) is an integrated travel company with an airline at its heart, focused on connecting customers with the people, places and experiences that matter most.
  • Since 1999, Allegiant Air has linked travelers in small-to-medium cities to world-class vacation destinations with all-nonstop flights and industry-low average fares.
  • Today, Allegiant serves communities across the nation, with base airfares less than half the cost of the average domestic roundtrip ticket.